Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
about
ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.HAEMORRHAGE AND FIBRINOLYSIS.In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.Cryofibrinogenemia and cerebrovascular accidentGeneralized Shwartzman reaction due to gram-negative septicemia after abortion: recovery after bilateral cortical necrosis.Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.Coagulation studies in massive pulmonary haemorrhage of the newborn.Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine.Acute promyelocytic leukemia with hypofibrinogenemiaAmino acid composition of human fibrinogen and anticoagulant derivatives.Intravascular coagulation in a case of Clostridium perfringens septicaemia: treatment by exchange transfusion and heparin.Epistaxis Treated with Epsilon-Amino-n-Caproic Acid
P2860
Q33954645-243D3DAD-D34C-4584-A548-A52CC4E7B4CBQ34019785-E54F5DF5-1193-4198-B65A-4D14C5144CD8Q35410106-2F67E560-F445-48D6-AE69-A02D793CE633Q35853857-1B1C062E-4746-419C-BE2D-9DE152DFAA36Q35864477-A4089BE1-17E6-4948-BDBC-2BAA8B42E237Q35899867-E78590B0-2DB2-46DE-BBBF-571BF7163876Q35900011-E9C3D412-8DE5-40F5-86D0-7E997DE3A068Q36515712-CE6C6D9F-D388-4B00-B9A1-ADE90CB2AC90Q36520025-390DF019-FF0C-4577-AFF0-B9506056304BQ37097524-504F2695-81B6-48F1-877E-1365D2961B2AQ40319156-DBB6B130-4377-4D9D-80E4-8666D6432AB2Q41254065-FFE21C5A-E8B0-418A-8BB0-6EAA11C00F9FQ41654876-D6C997A0-BEB3-41A9-AAA0-3D8F4B44E69EQ42176610-6C50E802-EECA-4706-91F3-5F393087D198Q51202603-A2F6E7DC-2521-48E4-9C61-7EB34DD1D066Q58083634-2325D0E5-CBE2-4D94-BC59-6F6BABC45F38
P2860
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
description
1962 nî lūn-bûn
@nan
1962 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1962 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1962年の論文
@ja
1962年論文
@yue
1962年論文
@zh-hant
1962年論文
@zh-hk
1962年論文
@zh-mo
1962年論文
@zh-tw
1962年论文
@wuu
name
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@ast
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@en
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic
@nl
type
label
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@ast
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@en
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic
@nl
prefLabel
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@ast
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@en
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic
@nl
P2093
P2860
P356
P1476
Pathogenesis of the coagulatio ...... fibrinogen breakdown products.
@en
P2093
ALKJAERSIG N
FLETCHER AP
P2860
P304
P356
10.1172/JCI104546
P407
P577
1962-04-01T00:00:00Z